AnaptysBio, Inc. (ANAB) by event type
ANAB moves most on analyst upgrades — a median of -2.40% at 30 minutes across 14 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the ANAB overview →
How ANAB reacts across 6 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 2,701 of 2,717 | 14 | -2.40% | 36% | -3.68% |
| Analyst downgrades 1,608 of 2,603 | 11 | -0.06% | 46% | +3.39% |
| Coverage initiations 2,013 of 2,283 | 28 | -0.69% | 46% | -0.32% |
| Rating reiterations 84 of 3,522 | 94 | +0.72% | 63% | +0.16% |
| Price-target raises 27 of 1,790 | 21 | +0.64% | 52% | +0.24% |
| Price-target cuts 248 of 1,527 | 12 | +0.17% | 50% | +0.70% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.
That’s how ANAB usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · ANAB overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Avid Bioservices, Inc. (CDMO) | 354 | 0.00% | 49% |
| Celcuity Inc. (CELC) | 354 | +0.13% | 52% |
| REGENERX BIOPHARMS INC (RGRX) | 343 | 0.00% | 36% |
| Allena Pharmaceuticals, Inc. (ALNA) | 342 | 0.00% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.